The new engine is already turning: a recently live driver is producing real business now, and management says the report
The model's full reasoning — Q4 2016 call → NOWe need to determine if management identifies a specific newer driver of business that is already producing real business now and that the reported period caught only the start of it. The transcript discusses Opdivo, Yervoy, Eliquis, etc. But the question asks for a specific newer driver. Possibly the international business for Opdivo? Or the launch of head-and-neck indication? Or bladder approval expected? But bladder is not yet approved. The international business for Opdivo: they mention completing price negotiations in France and Germany, recognizing revenue, and expect continued growth. But is that a "newer driver"? It's part of existing business. The question asks for a specific identifiable thing such as a new contract, program, product, etc. Look for something that is already producing and early stage. For example, they mention "recently launched head-and-neck indication" and "expected bladder approval" but bladder not yet. Head-and-neck is launched. But is it described as early? They say "very early launch, but execution looks good in head-and-neck." That could be a driver. But is it significant enough? They mention it as part of non-lung business. Also they mention "our recently launched head-and-neck indication" in Giovanni's remarks. But they don't quantify or say it's a major driver. They also mention "we are also getting some non-promoted sales in small-cell lung cancer" but that's off-label. Another possibility: The international business for Opdivo. They say "our teams have done a great job with access and reimbursement. You've seen that in our full-year results. Specifically in the quarter, we completed price negotiations for France and Germany. Overall, I expect to see continued growth internationally in 2017." That is about existing business expanding. Not necessarily a new driver. The question asks for a specific newer driver that is already producing real business now and that the reported period caught only the start. For example, a new product launch, a new indication, a new market entry. The head-and-neck indication is a new launch. They say "very early launch" and "execution looks good." That suggests it's early. But is it a major driver? They don't give numbers. Also they mention "expected bladder approval" but that's not yet. Another possibility: The Opdivo/Yervoy combination in melanoma? That's existing.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| FWONK | Formula One Group | Q1 2024 | 2024-05-08 | C+ |
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| JLL | Jones Lang LaSalle Incorporated | Q3 2023 | 2023-11-02 | F |
| AEP | American Electric Power Company, Inc. | Q3 2023 | 2023-11-02 | C+ |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| TGT | Target Corporation | Q4 2022 | 2023-02-28 | C |
| BLZE | Backblaze, Inc. | Q3 2022 | 2022-11-11 | D |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| XHR | Xenia Hotels & Resorts, Inc. | Q2 2022 | 2022-08-05 | A |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| SLQT | SelectQuote, Inc. | Q2 2022 | 2022-02-07 | F |
| FORM | FormFactor, Inc. | Q4 2021 | 2022-02-02 | B |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| MAS | Masco Corporation | Q3 2018 | 2018-10-30 | C |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| BDC | Belden Inc. | Q4 2016 | 2017-02-02 | B |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
| CAL | Caleres, Inc. | Q4 2015 | 2016-03-15 | C+ |
OOMA · Q3 2022 → YESThe question is about whether management identifies a specific newer driver of business that is already producing real business now, but the reported period caught only the start of it. YES The transcript identifies the largest customer's expansion as the specific newer driver. Management describes launching service at approximately thirty new locations during Q3 (actual transactions occurring in the reported period) while noting that "this month, we are rolling out to several additional locations" and planning a "larger scale rollout early next year," with 30 locations already added and "we are now quite close to executing our full plan." This framing shows the reported period captured only the early stage of the ramp, as the full scale is still ahead.
TGT · Q4 2022 → YESThe question is whether management identifies a SPECIFIC NEWER DRIVER OF BUSINESS that is already producing real business now, but the reported period caught only the start of it. YES The specific newer driver is Drive-Up returns. It started as a pilot last year (so some activity in the reported period), but management announces it today as the next phase now being rolled out across the chain by end of summer, meaning the reported period captured only the early/pilot stage while the broader delivery and 2023 contribution are still ramping. This is presented as already producing real business (pilot) but with most committed activity ahead, and it is meaningfully tied to scaling the stores-as-hub model.
BDC · Q4 2016 → YESThe question is about whether management identifies a specific newer driver of business that is already producing real business now, but the reported period caught only the start of it. YES The transcript identifies Grass Valley's open-architecture IP infrastructure system as the specific newer driver. Management describes it as already transacting via a significant multimillion-dollar order won in Q4 (with 11% orders growth and book-to-bill of 1.